+ All Categories
Home > Documents > phs-eg.comDr. Abd El Wahab Mohamed Innovative Medicines in Egypt: Our own experience with...

phs-eg.comDr. Abd El Wahab Mohamed Innovative Medicines in Egypt: Our own experience with...

Date post: 02-Jun-2020
Category:
Upload: others
View: 0 times
Download: 0 times
Share this document with a friend
24
Transcript
Page 1: phs-eg.comDr. Abd El Wahab Mohamed Innovative Medicines in Egypt: Our own experience with cyclocreatine as a Novel FDA-Designated Cardioprotective drug Prof. Salwa Elgebaly Update
Page 2: phs-eg.comDr. Abd El Wahab Mohamed Innovative Medicines in Egypt: Our own experience with cyclocreatine as a Novel FDA-Designated Cardioprotective drug Prof. Salwa Elgebaly Update
Page 3: phs-eg.comDr. Abd El Wahab Mohamed Innovative Medicines in Egypt: Our own experience with cyclocreatine as a Novel FDA-Designated Cardioprotective drug Prof. Salwa Elgebaly Update
Page 4: phs-eg.comDr. Abd El Wahab Mohamed Innovative Medicines in Egypt: Our own experience with cyclocreatine as a Novel FDA-Designated Cardioprotective drug Prof. Salwa Elgebaly Update
Page 5: phs-eg.comDr. Abd El Wahab Mohamed Innovative Medicines in Egypt: Our own experience with cyclocreatine as a Novel FDA-Designated Cardioprotective drug Prof. Salwa Elgebaly Update
Page 6: phs-eg.comDr. Abd El Wahab Mohamed Innovative Medicines in Egypt: Our own experience with cyclocreatine as a Novel FDA-Designated Cardioprotective drug Prof. Salwa Elgebaly Update
Page 7: phs-eg.comDr. Abd El Wahab Mohamed Innovative Medicines in Egypt: Our own experience with cyclocreatine as a Novel FDA-Designated Cardioprotective drug Prof. Salwa Elgebaly Update
Page 8: phs-eg.comDr. Abd El Wahab Mohamed Innovative Medicines in Egypt: Our own experience with cyclocreatine as a Novel FDA-Designated Cardioprotective drug Prof. Salwa Elgebaly Update
Page 9: phs-eg.comDr. Abd El Wahab Mohamed Innovative Medicines in Egypt: Our own experience with cyclocreatine as a Novel FDA-Designated Cardioprotective drug Prof. Salwa Elgebaly Update
Page 10: phs-eg.comDr. Abd El Wahab Mohamed Innovative Medicines in Egypt: Our own experience with cyclocreatine as a Novel FDA-Designated Cardioprotective drug Prof. Salwa Elgebaly Update
Page 11: phs-eg.comDr. Abd El Wahab Mohamed Innovative Medicines in Egypt: Our own experience with cyclocreatine as a Novel FDA-Designated Cardioprotective drug Prof. Salwa Elgebaly Update
Page 12: phs-eg.comDr. Abd El Wahab Mohamed Innovative Medicines in Egypt: Our own experience with cyclocreatine as a Novel FDA-Designated Cardioprotective drug Prof. Salwa Elgebaly Update

Moderators: Prof. Nawal Khalafallah, Prof. Mahmoud M. El-Mas

Opening/ Plenary Session

Hormonal treatments for prostate adenocarcinomaProf. Ahmed Elabbady

Future directions in the treatment of overactive bladder syndromeProf. Martin Michel

Medication Therapy Management (MTM) of prostate cancer: a clinical pharmacy perspectiveDr. Noha El Bassiouny

Moderator: Prof. Fouad Sharabi

Pharmacology, Pharmacotherapy, Healthcare

Highlights of hypertensive and vasculotoxic e�ects of cyclosporineProf. Mahmoud M. El-Mas

Sano� CHC Egypt portfolioDr. Abd El Wahab Mohamed

Innovative Medicines in Egypt: Our own experience with cyclocreatine as aNovel FDA-Designated Cardioprotective drugProf. Salwa Elgebaly

Update in Treatment of hypertensionProf. Amr Zaki

MAIN HALL

HALL A

09:30 - 11:00

12:00 - 13:30

13:30 - 14:00

11:30 - 12:00 | Co�ee Break & Posters Session

08:30 - 09:30 | Registration

SESSION

Sano� Session

A11

HALL A

Wednesday 6th November 2019Hilton Alexandria Green Plaza Hotel, Alexandria, Egypt

DAY ONE

10

Page 13: phs-eg.comDr. Abd El Wahab Mohamed Innovative Medicines in Egypt: Our own experience with cyclocreatine as a Novel FDA-Designated Cardioprotective drug Prof. Salwa Elgebaly Update

HALL A

A12Moderator: Prof. Ahmed Shama

Pharmacology, Pharmacotherapy, Healthcare

Evolution of medical treatment in Diabetic Macular EdemaAssoc. Prof. Ahmed Souka

Modulating adipose in�ammation as an early target in diabetic vascular dysfunction:novel therapeutic toolsAssoc. Prof. Ahmed Elyazbi

Clinical Pharmacy in Oncology Practice…One TeamDr. Hazem El Mansy

15:00 - 16:30

14:00 - 15:00 | Lunch Break

SESSION

HALL A

Opening Ceremony17:00 - 18:00

PHS 2019International Conference on

PHARMACEUTICAL & HEALTHCARE SCIENCES

11

Page 14: phs-eg.comDr. Abd El Wahab Mohamed Innovative Medicines in Egypt: Our own experience with cyclocreatine as a Novel FDA-Designated Cardioprotective drug Prof. Salwa Elgebaly Update

B11Moderator: Prof. Amal Galal

Pharmacy Education

As a Pharmacy profession: where are we going?Prof. Moustafa Fahmy

Bringing advanced analytical tools to your door stepDr. Mai Osama

Transforming a BPharm into a PharmD: a Paradigm ShiftProf. Pierre Moreau

Development of Competency-Based Pharmacy EducationAssoc. Prof. Andries Koster

12:00 - 13:30SESSION

13:30 - 14:00 Nawwah Session

14:00 - 15:00 | Lunch Break

HALL B

HALL B

Wednesday 6th November 2019Hilton Alexandria Green Plaza Hotel, Alexandria, Egypt

DAY ONE

12

Page 15: phs-eg.comDr. Abd El Wahab Mohamed Innovative Medicines in Egypt: Our own experience with cyclocreatine as a Novel FDA-Designated Cardioprotective drug Prof. Salwa Elgebaly Update

C11Moderators: Prof. Labiba ElKhordagy, Assoc. Prof. Alyaa Ramadan

Research Oral Presentations

Prodigiosin-functionalized bacterial ghosts: a novel bioinspired delivery systemagainst colorectal cancerDr. Nessrin S. Mohamed

Preparation, characterization and in-vivo evaluation of glibenclamide solid solutionsusing injection molding techniqueDr. Ahmed Fathy Hanafy

Preparation of micellar curcumin-spray dried powder formulated in sublingualtablet for oral deliveryDr. Helmy Yusuf

Dosing accuracy of measuring devices provided with antibiotic oral suspensionsand used by the Lebanese mothersDr. Fadi M. Hodeib

Role of Pharmacovigilance in Patient Safety and Public HealthDr. Sohaila G. Salama

Economic evaluation of the clinical pharmacist role in rationalizing antibioticprescriptions in outpatient clinicsDr. Shaimaa A. Abdelmoneim

12:00 - 14:00SESSION

HALL C

14:00 - 15:00 | Lunch Break

HALL C

C12 Workshop 1

How to design integrated courses

15:00 - 17:00SESSION

PHS 2019International Conference on

PHARMACEUTICAL & HEALTHCARE SCIENCES

13

Page 16: phs-eg.comDr. Abd El Wahab Mohamed Innovative Medicines in Egypt: Our own experience with cyclocreatine as a Novel FDA-Designated Cardioprotective drug Prof. Salwa Elgebaly Update

D11Moderator: Prof. Nawal Khalafallah

Pharmacy Practice & Clinical Pharmacy

Clinical Pharmacy, Paradigm that Expands the Medical ProfessionProf. Nermine Sabry

Pharmacovigilance and Medication Safety in the Middle EastAssoc. Prof. Thamir M. Alshammari

New Excellence in PharmacovigilanceDr. Amr Saad

15:00 - 16:30SESSION

HALL D

Wednesday 6th November 2019Hilton Alexandria Green Plaza Hotel, Alexandria, Egypt

DAY ONE

14

Page 17: phs-eg.comDr. Abd El Wahab Mohamed Innovative Medicines in Egypt: Our own experience with cyclocreatine as a Novel FDA-Designated Cardioprotective drug Prof. Salwa Elgebaly Update

15

PHS 2019

Page 18: phs-eg.comDr. Abd El Wahab Mohamed Innovative Medicines in Egypt: Our own experience with cyclocreatine as a Novel FDA-Designated Cardioprotective drug Prof. Salwa Elgebaly Update

A21SESSION

Moderator: Prof. Magda EL-Massik

Pharmaceutical Technology/ Nanomedicine

Pharmaceutical Technology/ Nanomedicine

HALL A

HALL A

09:30 - 11:00

12:00 - 14:00

11:30 - 12:00 | Co�ee Break & Posters Session

SESSIONA22

Nanoparticle-based strategies in OncolgyProf. Jean Pierre Benoit

Intersection of drug repurposing and nanotechnology: Emerging opportunities fornew therapiesProf. Labiba Elkhordagy

New insights into the pharmacokinetics of nanoparticles (video conference)Prof. Frederic Lagarce

Moderator: Prof. Nazik Elgindy

Nanoparticles and rod-like particles for inhalation drug deliveryProf. Marc Schneider

Lipoprotein-mimicking nanocarriers in cancer therapyAssoc. Prof. Yosra Elnaggar

“Formulation of lipid nanocapsules with linalool: Investigation into antibacterialproperties and uptake by bacterial cells

Research Oral presentation:

Assoc. Prof. Alyaa Ramadan

Advances in Clinical Ophthalmology: triumphs and tribulations for e�ective and safedrug delivery systems to the eyeAssoc. Prof. Hamdy Abdel Kader

08:30 - 09:30 | Registration

DAY TWOThursday 7th November 2019

Hilton Alexandria Green Plaza Hotel, Alexandria, Egypt

16

Page 19: phs-eg.comDr. Abd El Wahab Mohamed Innovative Medicines in Egypt: Our own experience with cyclocreatine as a Novel FDA-Designated Cardioprotective drug Prof. Salwa Elgebaly Update

14:00 - 15:00 | Lunch Break

A23SESSION

Moderator: Prof. Mohamed Etman

Pharmacy Education and Practice

HALL A15:30 - 17:00

Development of pharmacy education: non-western prospectiveDr. Amira Khalil

Role of clinical pharmacist in Dual Antiplatlet Therapy (DAPT) choice inAcute Coronary Syndrome (ACS).Pharm D Clinical Pharmacist Rasha Wafaie

Challenges in Psychiatric Pharmacy Practice.The Role of Community and Clinical Pharmacists in Psychoeducation.Pharm D Clinical Pharmacist Nancy Ali Mahfouz

Orchidia Session

HALL A15:00 - 15:30

Orchidia “state of the art manufacturing technology”Dr. Ahmed Mamdouh

HALL A

Closing Ceremony17:00 - 18:00

PHS 2019International Conference on

PHARMACEUTICAL & HEALTHCARE SCIENCES

17

Page 20: phs-eg.comDr. Abd El Wahab Mohamed Innovative Medicines in Egypt: Our own experience with cyclocreatine as a Novel FDA-Designated Cardioprotective drug Prof. Salwa Elgebaly Update

B21SESSION

HALL B

09:30 - 11:30

Moderator: Prof. Elsayed Aboulmagd

Microbiology & Immunology

Towards AMR Containment in AfricaProf. Sabiha Essack

Coagulase-negative staphylococci (CoNS): Hidden champions at the crossroadbetween humans, animals and the environmentProf. Wilma Ziebuhr

The great escape from “ESKAPE” pathogens. An overview of our �ve-yearvaccine researchAssoc. Prof. Mohammed Bahey-El-DinResearch Oral presentation:

B22SESSION

HALL B

11:30 - 12:00 | Co�ee Break & Posters Session

Moderator: Prof. Fathallah Harraz

Drug Discovery; Pharm. Analysis; Phytotherapy

Imidazo[2',1':2,3]thiazolo[4,5-d]pyridazin Analogues as New Sca�old of DHFR InhibitorsProf. Hussein I. El-Subbagh

Mining natural libraries for new glycan interactions using native mass spectrometryProf. John Klassen

Molecular modeling: a tool to tackle selectivity among closely related isozymesDr. Amgad Elbohy

12:00 - 13:30

DAY TWOThursday 7th November 2019

Hilton Alexandria Green Plaza Hotel, Alexandria, Egypt

18

“In-vivo evaluation of Klebsiella pneumoniae outer membrane proteins OmpK36 andOmpK17 as potential vaccine candidates”Dr. Kawther E. Hussein

Page 21: phs-eg.comDr. Abd El Wahab Mohamed Innovative Medicines in Egypt: Our own experience with cyclocreatine as a Novel FDA-Designated Cardioprotective drug Prof. Salwa Elgebaly Update

14:00 - 15:00 | Lunch Break

B23SESSION

HALL B

15:00 - 16:30

Moderator: Assoc. Prof. Essam Khamis

Drug Discovery; Pharm. Analysis; Phytotherapy

Biochemistry era to drive modern drug discovery; implication of the adventurersProf. Nadia Hamdy

Quali�cation of DNA damage induced by di�erent pharmaceuticalsAssoc. Prof. Amira Elyazbi

“Development and validation of UPLC-MS/MS method for the simultaneousquanti�cation of dasabuvir, tamoxifen and its active metabolite 4- hydroxytamoxifenin Wistar rat plasma: Application to pharmacokinetic interaction study”

“Application of logistic versus logarithmic functions for modeling non-linear evaporativelight scattering detector responses in the HPLC quantitation of two non-chromophoriccompounds of pharmaceutical interest”

“A newly-developed LC-MS method to study possible pharmacokinetic interactionbetween Linaglptin and Tadala�l upon co-administration in healthy male volunteers”

Research Oral presentation:

Prof. Hadir Maher

Dr. Miranda K.Fawzy

Dr. Sara Samy

PHS 2019International Conference on

PHARMACEUTICAL & HEALTHCARE SCIENCES

19

Page 22: phs-eg.comDr. Abd El Wahab Mohamed Innovative Medicines in Egypt: Our own experience with cyclocreatine as a Novel FDA-Designated Cardioprotective drug Prof. Salwa Elgebaly Update

C21Moderators: Prof. Nadia Elsebakhy, Prof. Hanan El-Gowelli

Research Oral Presentations

Discovery of Unique Naturally Occurring Oligosaccharides with Diverse BiologicalPotentialitiesDr. Amr Mostafa Elhawiet

Prediction of potential cancer-related molecular targets of North African plantsconstituents using network pharmacology-based analysisDr. Eman Shawky

Phytochemical and biological investigations of Crocus sativus cultivated in theUniversity botanical gardenDr. Karim Rafaat

Simultaneous determination of Oleuropein biomarker by validated RP-HPTLC methodin nine varieties of olive leaves cultivated in EgyptDr. Hala H. Zaatout

A validated UPLC-PDA method for simultaneous determination of three biologicallyactive iso�avans in Trigonellastellata extractDr. Safa Shams

Metabolite pro�ling of di�erent-aged alfalfa sprouts using HPTLC image analysis�ngerprint-e�cacy relationship coupled with chemometricsDr. Reham Said

Early Renal Manifestations of Metabolic Challenge:BRenovascular DysfunctionPreceding HyperglycemiaDr. Safa Hammoud

Molecular Mechanism of Tadala�lAntinociceptive E�ect in an In�ammatory Pain ModelDr. Souraya A. Domiati

09:30 - 11:30SESSION

HALL C

11:30 - 12:00 | Co�ee Break & Posters Session

DAY TWOThursday 7th November 2019

Hilton Alexandria Green Plaza Hotel, Alexandria, Egypt

20

Page 23: phs-eg.comDr. Abd El Wahab Mohamed Innovative Medicines in Egypt: Our own experience with cyclocreatine as a Novel FDA-Designated Cardioprotective drug Prof. Salwa Elgebaly Update

C22Moderator: Prof. Nadia Hamdy

12:00 - 13:30SESSION

HALL C

Biotechnology & Genomics

Pharmacogenomic biomarkers for personalised liver diseases treatment:current and future prospectivesAssoc. Prof. Ahmed Wahid

Genomic epidemiology of transmission and antimicrobial resistance ofCampylobacter from farm to forkAssoc. Prof. Mohamed Elhadidi

System Biology and Genomics of Microbial PathogensProf. Ramy Aziz

14:00 - 15:00 | Lunch Break

HALL C

C23 Workshop 2

Antimicrobial Stewardship, Meet the Experts!

15:00 - 17:00SESSION

PHS 2019International Conference on

PHARMACEUTICAL & HEALTHCARE SCIENCES

21

Page 24: phs-eg.comDr. Abd El Wahab Mohamed Innovative Medicines in Egypt: Our own experience with cyclocreatine as a Novel FDA-Designated Cardioprotective drug Prof. Salwa Elgebaly Update

Recommended